Literature DB >> 6742927

An epidemiological study of scabies in a rural community in India.

R S Sharma, R S Mishra, D Pal, J P Gupta, M Dutta, K K Datta.   

Abstract

An epidemiological survey for scabies was conducted in a rural community of 2771 persons among 404 households living in 238 houses. Prevalence rates were 13% by population and 30.9% by household. Each index case was responsible, on average, for the spread of infection to 1.9 persons in affected households. Significantly lower rates of secondary attack and transmissibility were observed among the more prosperous villagers. The proportion of infected households increased linearly with household size. The prevalence was highest in those aged up to 19 years, both sexes being affected equally. An average morbidity duration for scabies was 64.5 days; 16.3% of the patients showed secondary pyogenic infection of the skin.

Entities:  

Mesh:

Year:  1984        PMID: 6742927     DOI: 10.1080/00034983.1984.11811789

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  4 in total

Review 1.  Epidermal parasitic skin diseases: a neglected category of poverty-associated plagues.

Authors:  Hermann Feldmeier; Jorg Heukelbach
Journal:  Bull World Health Organ       Date:  2009-02       Impact factor: 9.408

2.  Mass scabies management in an orphanage of rural community: An experience.

Authors:  Sunil Agrawal; Atul Puthia; Atul Kotwal; Rina Tilak; Renuka Kunte; A S Kushwaha
Journal:  Med J Armed Forces India       Date:  2012-08-24

3.  The spectrum of dermatological disorders among primary school children in Dar es Salaam.

Authors:  Ewaldo V Komba; Yassin M Mgonda
Journal:  BMC Public Health       Date:  2010-12-16       Impact factor: 3.295

Review 4.  The Global Epidemiology of Impetigo: A Systematic Review of the Population Prevalence of Impetigo and Pyoderma.

Authors:  Asha C Bowen; Antoine Mahé; Roderick J Hay; Ross M Andrews; Andrew C Steer; Steven Y C Tong; Jonathan R Carapetis
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.